EANS-News: PVA TePla AG / Excellent figures for 2011
Geschrieben am 13-03-2012 |
--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------
annual report
Wettenberg (euro adhoc) - • Sales revenues of EUR 132.6 million
(previous year: EUR 120.4 million) • Incoming orders of EUR
156.2 million (previous year: EUR 93.4 million) • Order backlog
of EUR 74.9 million (previous year: EUR 52.9 million)
(Wettenberg, March 13, 2012) - PVA TePla AG, Wettenberg-Germany, a
manufacturer of silicon crystallization systems, vacuum and
high-temperature systems, has published its provisional consolidated
figures for fiscal 2011, which show a pleasing increase over fiscal
2010. PVA TePla AG generated consolidated sales revenues of EUR 132.6
million (previous year [PY]: EUR 120.4 Mio), slightly higher than its
previously advised forecast.
The rise in incoming orders to EUR 156.2 million was particularly
significant, resulting in correspondingly higher order backlog of
currently EUR 74.9 million as of December 31, 2011 (comparative
figures for 2010: incoming orders of EUR 93.4 million and order
backlog of EUR 52.9 million).
At EUR 57.0 million, the Industrial Systems division´s sales revenues
were twice as high as in fiscal 2010 (EUR 28.4 million). This is the
highest sales revenue figure for this division in the history of the
company. The development in incoming orders was also very promising,
rising to a record level of EUR 59.2 million (PY: EUR 40.8 million).
Vacuum systems were mainly provided to customers on the hard metals
market.
Sales revenues in the Semiconductor Systems division also rose
significantly year-on-year in 2011 to EUR 49.3 million (PY: EUR 33.9
million). The strong rise in sales revenues is due to the
crystal-growing system business units for the semiconductor industry
(Czochralski and float-zone processes). The PVA TePla Analytical
Systems subsidiary posted stable sales revenues at a high level in
2011. Sales revenues in the plasma systems product group even
improved slightly. The Semiconductor Systems division also saw high
growth in incoming orders from EUR 42.5 million in 2010 to EUR 68.1
million in 2011.
In a challenging market environment, sales revenues in the Solar
Systems division declined to EUR 26.3 million in the past fiscal year
(PY: EUR 58.1 million). Sales revenues essentially related to an
order received in April 2011 to provide systems for the production of
monocrystalline silicon crystals in Asia. Incoming orders increased
as a result of the above order to EUR 28.9 million (PY: EUR 10.1
million) and at least matched the 2009 level after a weak 2010.
EBIT, which was forecast at between 8% and 10%, will slightly exceed
10% in 2011.
Further figures will be described in a press release on March 29,
2012 in connection with the publication of the annual report for PVA
TePla AG.
The current forecast for fiscal 2012 has been confirmed. Thus,
consolidated sales revenues are expected to amount to between EUR 120
million and EUR 130 million. An EBIT margin of 8%-10% is anticipated.
Further inquiry note:
Dr. Gert Fisahn
Telefon: +49(0)641 68690-400
E-Mail: gert.fisahn@pvatepla.com
end of announcement euro adhoc
--------------------------------------------------------------------------------
company: PVA TePla AG
Im Westpark 10-12
D-35435 Wettenberg
phone: +49(0)641 68690-0
FAX: +49(0)641 68690-800
mail: ir@pvatepla.com
WWW: http://www.pvatepla.com
sector: Misc. Industrials
ISIN: DE0007461006
indexes: CDAX
stockmarkets: free trade: Hannover, Berlin, München, Hamburg, Düsseldorf,
Stuttgart, regulated dealing/prime standard: Frankfurt
language: English
Kontaktinformationen:
Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.
Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.
Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.
http://www.bankkaufmann.com/topics.html
Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.
@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf
E-Mail: media(at)at-symbol.de
383523
weitere Artikel:
- EANS-News: PVA TePla AG / Sehr gute Geschäftszahlen für 2011 --------------------------------------------------------------------------------
Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der
Emittent/Meldungsgeber verantwortlich.
--------------------------------------------------------------------------------
Jahresgeschäftsbericht
Wettenberg (euro adhoc) - • Umsatz bei 132,6 Mio. Euro (VJ 120,4 Mio.
Euro)
• Auftragseingang bei 156,2 Mio. Euro (VJ 93,4 Mio. Euro)
• Auftragsbestand bei 74,9 Mio. Euro (VJ 52,9 Mio. Euro)
(Wettenberg, 13.03.2012) - Die mehr...
- EANS-News: DSM und Agennix unterzeichnen neue Vereinbarung für kommerzielle
Produktion von Talactoferrin --------------------------------------------------------------------------------
Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der
Emittent/Meldungsgeber verantwortlich.
--------------------------------------------------------------------------------
Verträge
Planegg/München und US-Standorte in Princeton, NJ, und Houston, TX,
13. März 2012 (euro adhoc) - DSM Pharmaceutical Products, die
Geschäftseinheit Lohnherstellung der Royal DSM N.V. (NYSE, Euronext:
DSM KON), und Agennix AG (Frankfurter Wertpapierbörse: mehr...
- EANS-News: DSM and Agennix Sign New Contract for Commercial Manufacture of
Talactoferrin --------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------
Contracts
Planegg/Munich (Germany), Princeton, NJ and Houston, TX, March 13,
2012 (euro adhoc) - DSM Pharmaceutical Products, the custom
manufacturing business of Royal DSM N.V. (NYSE, Euronext: DSM KON),
and Agennix AG (Frankfurt Stock Exchange: mehr...
- EANS-News: Identive Group Inc. / Innovative Technologie für Zugangskontrolle von
Identive revolutioniert integriertes Identity-Management --------------------------------------------------------------------------------
Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der
Emittent/Meldungsgeber verantwortlich.
--------------------------------------------------------------------------------
Marketing
Utl.: Neue Leserfamilie ermöglicht rasche Verknüpfung von physischem
und logischem Zugang
Santa Ana und Ismaning, 13. März 2012 (euro adhoc) - Die Identive
Group, Inc. (NASDAQ: INVE; Frankfurt: INV), ein führender Anbieter
von Produkten, Diensten und mehr...
- EANS-News: Identive Group Inc. / Innovative Access Control Technology from
Identive Revolutionizes Integrated Identity Management --------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------
Marketing
Subtitle: New reader family enables rapid convergence of physical and
logical access
SANTA ANA, Calif. and ISMANING, Germany, March 13, 2012 (euro adhoc)
- Identive Group, Inc. (NASDAQ: INVE: Frankfurt: INV), today
introduced TouchSecure mehr...
|
|
|
Mehr zu dem Thema Finanzen
Der meistgelesene Artikel zu dem Thema:
Century Casinos wurde in Russell 2000 Index aufgenommen
durchschnittliche Punktzahl: 0 Stimmen: 0
|